Toxic megacolon surgery: Difference between revisions
No edit summary |
Farima Kahe (talk | contribs) |
||
Line 22: | Line 22: | ||
Surgery is the mainstay of treatment for [disease or malignancy]. | Surgery is the mainstay of treatment for [disease or malignancy]. | ||
==Surgery== | ==Surgery== | ||
*The mainstay of treatment for toxic megacolon is medical therapy. Surgery is usually reserved for patients with | |||
**Failed medical therapy | |||
*The mainstay of treatment for | |||
** | |||
**[Indication 2] | **[Indication 2] | ||
**[Indication 3] | **[Indication 3] | ||
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | *The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | ||
==Indications== | ==Indications== |
Revision as of 16:51, 8 November 2017
Toxic Megacolon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic megacolon surgery On the Web |
American Roentgen Ray Society Images of Toxic megacolon surgery |
Risk calculators and risk factors for Toxic megacolon surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Surgery
- The mainstay of treatment for toxic megacolon is medical therapy. Surgery is usually reserved for patients with
- Failed medical therapy
- [Indication 2]
- [Indication 3]
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.